共 11 条
- [3] Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort Rheumatology International, 2020, 40 : 263 - 272
- [4] Real-World Outcomes of a Mandatory Adalimumab Non-Medical Biosimilar Switch for Patients With Inflammatory Bowel Disease: A Single Center Retrospective Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S748 - S749
- [6] Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study Annals of Hematology, 2010, 89 : 851 - 859
- [7] Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
- [8] A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naive patients and in patients undergoing non-medical switch from originator CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1099 - 1102